Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr 23;11(9):2375.
doi: 10.3390/jcm11092375.

Quality of Life and Excessive Daytime Sleepiness in Adults with Obstructive Sleep Apnea Who Are Treated with Multilevel Surgery or Adherent to Continuous Positive Airway Pressure

Affiliations

Quality of Life and Excessive Daytime Sleepiness in Adults with Obstructive Sleep Apnea Who Are Treated with Multilevel Surgery or Adherent to Continuous Positive Airway Pressure

Giannicola Iannella et al. J Clin Med. .

Abstract

Obstructive Sleep Apnea (OSA) syndrome is a respiratory sleep disorder characterized by a reduction (hypopnea) in or a complete cessation (apnea) of airflow in the upper airways at night, in the presence of breathing effort. The gold standard treatment for OSA is ventilation through continuous positive airway pressure (CPAP), although this often shows poor patient compliance. In recent years, transoral robotic surgery (TORS) has been proposed as a valid surgical treatment for patients suffering from OSA in a multilevel surgical setting. The aim of this study is to analyze the effects on QoL and daytime sleepiness of multilevel surgery for OSA (barbed pharyngoplasty + transoral robotic surgery). Furthermore, we compared the impact on QoL and daytime sleepiness of two different treatments for patients with moderate to severe OSA, such as CPAP and TORS. Sixty-seven OSA patients who underwent multilevel robotic surgery and sixty-seven OSA patients treated with CPAP were enrolled, defined as Group 1 and Group 2, respectively. The Glasgow Benefit Inventory (GBI) questionnaire was administrated to evaluate the changes in the QoL. Respiratory outcomes were evaluated and compared. Group 1 showed a GBI total average value of +30.4, whereas Group 2, a value of +33.2 (p = 0.4). General benefit score showed no difference between groups (p = 0.1). Better values of social status benefit (p = 0.0006) emerged in the CPAP Group, whereas greater physical status benefit (p = 0.04) was shown in the TORS Group. Delta-AHI (-23.7 ± 14.3 vs. -31.7 ± 15.6; p = 0.001) and Delta-ODI (-24.5 ± 9.5 vs. -29.4 ± 10.5; p = 0.001) showed better values in the CPAP group. Therapeutic success rate of the Multilevel TORS Group was 73.1% and 91% in the CPAP group (p = 0.01), respectively. Multilevel TORS and CPAP have a positive effect on the quality of life of OSA patients. Greater social support has been reported in the CPAP group and better physical health status in the TORS group. No statistical difference emerged in the reduction in daytime sleepiness between both groups.

Keywords: CPAP; Obstructive Sleep Apnea; quality of life; robotic surgery; sleep studies.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Box plot showing differences in OSA outcomes pre- and post TORS in a multilevel setting. Apnea Hypopnea Index (AHI); oxygen desaturation index (ODI); Epworth Sleepiness Scale (ESS).
Figure 2
Figure 2
Box plot showing differences in OSA outcomes pre- and post-CPAP treatment. Apnea Hypopnea Index (AHI); oxygen desaturation index (ODI); Epworth Sleepiness Scale (ESS).

References

    1. Berry R.B., Brooks R., Gamaldo C., Harding S.M., Lloyd R.M., Quan S.F., Troester M.T., Vaughn B.V. AASM Scoring Manual Updates for 2017 (Version 2.4) J. Clin. Sleep Med. 2017;13:665–666. doi: 10.5664/jcsm.6576. - DOI - PMC - PubMed
    1. Trzepizur W., Gagnadoux F. Epidemiology of obstructive sleep apnoea syndrome. Rev. Des. Mal. Respir. Elsevier Masson SAS. 2014;31:568–577. doi: 10.1016/j.rmr.2014.01.013. - DOI - PubMed
    1. Randerath W.J., Verbraecken J., Andreas S., Bettega G., Boudewyns A., Hamans E., Jalbert F., Paoli J.R., Sanner B., Smith I., et al. Non-CPAP therapies in obstructive sleep apnoea. Eur. Respir. J. 2011;37:1000–1028. doi: 10.1183/09031936.00099710. - DOI - PubMed
    1. Pauletto P., Réus J.C., Bolan M., Massignan C., Flores-Mir C., Maia I., Gozal D., Hallal A.L.C., Porporatti A.L., Canto G.D.L. Association between obstructive sleep apnea and health-related quality of life in untreated adults: A systematic review. Sleep Breath. 2021;25:1773–1789. doi: 10.1007/s11325-021-02323-1. - DOI - PubMed
    1. Berg L.M., Ankjell T.K.S., Sun Y.-Q., Trovik T.A., Rikardsen O.G., Sjögren A., Moen K., Hellem S., Bugten V. Health-Related Quality of Life and Sleep Quality after 12 Months of Treatment in Nonsevere Obstructive Sleep Apnea: A Randomized Clinical Trial with Continuous Positive Airway Pressure and Mandibular Advancement Splints. Int. J. Otolaryngol. 2020;2020:1–10. doi: 10.1155/2020/2856460. - DOI - PMC - PubMed

LinkOut - more resources